A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00297089 · COMPLETED

Trial details

NCT number: NCT00297089
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer NSCLC Non-Small-Cell Lung Cancer

Start date: 2006-11-01
Primary completion: 2009-01-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.